Acute renal failure in the newborn
SP Andreoli - Seminars in perinatology, 2004 - Elsevier
Acute renal failure in the newborn is a common problem and is typically classified as
prerenal, intrinsic renal disease including vascular insults, and obstructive uropathy. In the …
prerenal, intrinsic renal disease including vascular insults, and obstructive uropathy. In the …
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia
F Locatelli, JB Cannata‐Andía… - Nephrology Dialysis …, 2002 - academic.oup.com
Background. Disturbances of calcium‐phosphate (Ca‐P) metabolism in chronic renal
insufficiency (CRI) play an important role not only in bone disease (renal osteodystrophy) …
insufficiency (CRI) play an important role not only in bone disease (renal osteodystrophy) …
Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.
MS Sheikh, JA Maguire, M Emmett… - The Journal of …, 1989 - Am Soc Clin Investig
Antacids used to decrease phosphorus absorption in patients with renal failure may be toxic.
To find more efficient or less toxic binders, a three-part study was conducted. First …
To find more efficient or less toxic binders, a three-part study was conducted. First …
Calcium acetate, an effective phosphorus binder in patients with renal failure
ML Mai, M Emmett, MS Sheikh, CA Santa Ana… - Kidney International, 1989 - Elsevier
Calcium acetate, an effective phosphorus binder in patients with renal failure. Calcium salts
are increasingly used as phosphorus binders in patients with chronic renal failure. Calcium …
are increasingly used as phosphorus binders in patients with chronic renal failure. Calcium …
Chronic kidney disease mineral and bone disorder in children
K Wesseling, S Bakkaloglu, I Salusky - Pediatric Nephrology, 2008 - Springer
Childhood and adolescence are crucial times for the development of a healthy skeletal and
cardiovascular system. Disordered mineral and bone metabolism accompany chronic …
cardiovascular system. Disordered mineral and bone metabolism accompany chronic …
Phosphorus metabolism and management in chronic kidney disease: renal osteodystrophy, phosphate homeostasis, and vascular calcification
KA Hruska, G Saab, S Mathew, R Lund - Seminars in dialysis, 2007 - Wiley Online Library
New advances in the pathogenesis of renal osteodystrophy (ROD) change the perspective
from which many of its features and treatment are viewed. Calcium, phosphate, parathyroid …
from which many of its features and treatment are viewed. Calcium, phosphate, parathyroid …
The clinical impact of aluminium overload in renal failure
JB Cannata‐Andía… - Nephrology Dialysis …, 2002 - academic.oup.com
Chronic aluminium exposure and toxicity related to aluminium absorption and contaminated
dialysis fluid continue to be a problem for many patients with renal failure, particularly in …
dialysis fluid continue to be a problem for many patients with renal failure, particularly in …
Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
R Mathias, I Salusky, W Harman… - Journal of the …, 1993 - journals.lww.com
Renal bone disease has been well defined in adult patients receiving chronic dialysis and in
children on peritoneal dialysis/continuous ambulatory peritoneal dialysis. However, little is …
children on peritoneal dialysis/continuous ambulatory peritoneal dialysis. However, little is …
Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy
F Meric, P Yap, MJ Bia - American Journal of Kidney Diseases, 1990 - Elsevier
Fourteen of 39 dialysis patients (36%) became hypercalcemic after switching to calcium
carbonate as their principal phosphate binder. In order to identify risk factors associated with …
carbonate as their principal phosphate binder. In order to identify risk factors associated with …
Improving phosphate-binder therapy as a way forward
AJ Hutchison - Nephrology Dialysis Transplantation, 2004 - academic.oup.com
Aluminium-or calcium-based phosphate-binding agents traditionally have been used to treat
hyperphosphataemia in patients with end-stage renal disease. Although these agents …
hyperphosphataemia in patients with end-stage renal disease. Although these agents …